Viewing Study NCT01645293


Ignite Creation Date: 2025-12-25 @ 1:23 AM
Ignite Modification Date: 2026-06-10 @ 3:16 PM
Study NCT ID: NCT01645293
Status: UNKNOWN
Last Update Posted: 2012-07-20
First Post: 2012-07-11
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Multicentre Phase I Trial of Engineered T Cells for Patients With Relapsed or Refractory Primary Cutaneous CD30+ Large T Cell Lymphoma or Transformed CD30+ Mycosis Fungoides
Sponsor: University of Cologne
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None CD30 Positive Cutaneous T Cell Lymphoma View
None CD30 Positive Transformed Mycosis Fungoides View
Keywords: